Topics
- COVID-19 (102)
- Advertising (74)
- COVID-19 vaccines (63)
- Prescription medicines (29)
- Medical devices (20)
- Regulatory compliance (18)
- Alert/Advisory (14)
- Medicines safety (9)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Medicines (5)
- OTC medicines (3)
- Labelling and packaging (2)
- Shortages (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (1)
- Medicinal cannabis hub (1)
- Safety (1)
- Scheduling (1)
- Unapproved therapeutic goods (1)
Collection content
294 result(s) found, displaying 21 to 30
- NoticesGMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemicUpdate to GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemic.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 06-10-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA grants provisional determination to Moderna’s COVID-19 bivalent (Original plus Omicron BA.4/BA.5) booster dose vaccineThe TGA has granted a provisional determination to Moderna Australia Pty Ltd’s bivalent COVID-19 vaccine candidate: elasomeran and davesomeran (SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4/BA.5)
- Media releasesTGA provisionally approves Pfizer’s COVID-19 vaccine, COMIRNATY (tozinameran) for use in children aged 6 months to less than 5 yearsThe TGA has provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, COMIRNATY (tozinameran), for children aged 6 months to less than 5 years
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 23-09-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA provisionally approves Pfizer's COVID-19 vaccine, COMIRNATY (tozinameran), for use as a booster dose in individuals 5 years and olderThe TGA has provisionally approved Pfizer's COVID-19 vaccine, COMIRNATY (tozinameran) for use as a booster dose in individuals 5 years to 11 years.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 08-09-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesFirst combination COVID-19 and influenza self-tests approved for AustraliaThe TGA has approved the first two nasal combination self-tests (for use at home) that detect both COVID-19 and influenza viral infections in humans.
- Media releasesTGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adultsTGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 25-08-2022Information about the TGA's safety monitoring of COVID-19 vaccines.